Compare NRIX & HLIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | NRIX | HLIO |
|---|---|---|
| Founded | 2009 | 1970 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Metal Fabrications |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.5B | 2.6B |
| IPO Year | 2020 | 1996 |
| Metric | NRIX | HLIO |
|---|---|---|
| Price | $24.94 | $82.23 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 12 | 6 |
| Target Price | $30.50 | ★ $66.17 |
| AVG Volume (30 Days) | ★ 1.1M | 258.5K |
| Earning Date | 04-08-2026 | 05-11-2026 |
| Dividend Yield | N/A | ★ 0.72% |
| EPS Growth | N/A | ★ 23.93 |
| EPS | N/A | ★ 0.59 |
| Revenue | $76,987,000.00 | ★ $200,727,000.00 |
| Revenue This Year | N/A | $3.67 |
| Revenue Next Year | $48.05 | $5.00 |
| P/E Ratio | ★ N/A | $138.07 |
| Revenue Growth | ★ 99.31 | N/A |
| 52 Week Low | $8.20 | $47.05 |
| 52 Week High | $25.09 | $95.05 |
| Indicator | NRIX | HLIO |
|---|---|---|
| Relative Strength Index (RSI) | 66.01 | 54.22 |
| Support Level | $14.63 | $78.81 |
| Resistance Level | $24.98 | $83.99 |
| Average True Range (ATR) | 1.09 | 2.59 |
| MACD | -0.10 | 0.32 |
| Stochastic Oscillator | 79.66 | 79.95 |
Nurix Therapeutics Inc is a clinical-stage biopharmaceutical company focused on the discovery, development, and potential commercialization of targeted protein degradation therapies for cancer and inflammatory diseases. It utilizes an integrated discovery platform that incorporates artificial intelligence and ligase expertise to support its research activities. The company's pipeline includes Bexobrutideg (NX-5948), Zelebrudomide (NX-2127), NX-1607 and BRAF degrader. These drug candidates target specific proteins involved in immune and cancer-related pathways. It operates in a single business segment.
Helios Technologies Inc is an industrial technology company that develops, manufactures, and markets solutions for the hydraulics and electronics markets. It operates under two business segments: Hydraulics and Electronics. The Hydraulics segment designs and manufactures hydraulic components and systems used to transmit power and control force, speed, and motion. There are two categories based on Hydraulic system architecture: MCT and FCT. The Electronics segment provides complete, fully-tailored display and control solutions for engines, engine-driven equipment, specialty vehicles, therapy baths, and traditional and swim spas. The company generates the majority of its revenue from the Hydraulics segment. Geographically, the company generates key revenue from the Americas region.